Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

CD12 p value. Thanks tech, ohm, borel OK, so i

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153815
(Total Views: 730)
Posted On: 09/14/2020 5:54:01 PM
Posted By: havasu78
CD12 p value. Thanks tech, ohm, borel

OK, so i will try the CD12 p value again with the wolframalpha two binomial distribution test linked at the bottom of this post.

While I am trained as elec engineer, I am somewhat clueless on these combinatorial probablity problems

So maybe this is close. Or not.

ohm's post says the dexamethasone study mortality rate for patients on oxygen but not ventilated was 25%.

Thus perhaps 25% is a useful metric to use in the wolframalpha two binomial districution test.

25% mortality in placebo arm is about 16 deaths.

If 16 deaths in the Ll arm, that is a massive 50% reduction in mortality.

Running the wolfram alpha calculator for 16 deaths in each of placebo and LL arms yields pvalue of 0.02.

So that's pretty good. If mortality is as unfortunately as high as 25% in the placebo arm seems a pretty fair chance to hit the p value of 0.05.

When placebo has 16 deaths, LL can have 18 and still hit 0.05.

One thing I don't understand here is that TechGuru thinks that since the wolframalpha is a two tailed test. I am not sure if the two is because of two normal distributions (one placebo and one LL) or two tails on the plot (one tail on left side of graph, one tail on right side of graph).

Seems to me that "probablity of this outcome by chance" applies whether one or ten tails, but idk. also think wolframalpha would include any tail thingy in their answer, but idk.

borel thinks its probably not the calculator for the CD12 trial.

No doubt the FDA and CYDY have already agreed on not only the matth equations but also the success and fail p value mortality numbers.

Since the CD12 analysis of 195 patients is an "interim analysis", they probably have to hit a more difficult p value.

Just cuz why not, suppose LL reduces mortality by 75%. Then with 16 placebo deaths there are 8 leronlimab deaths.

Run the calculator and that's a p value of 0.0007.

Were this to occur, this is not a home run. this is knocking the ball out of the country.

UCLA EIND death rate I have read on this board was 2/28. (2/28)*130=9.2

so a massive success is not outside the realm of possibility.


(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us